ELYM (Eliem Therapeutics) Company Net Income

Official company branding of eliemtx.com (ELYM)

Geopolitical tensions are complicating reagent logistics and international scientific cooperation. The net earned profit of Eliem Therapeutics (ELYM), as shown on the GURU.Markets chart, demonstrates a resilient trend where the -0.06 level represents the current value. Development relies on a staff of neurobiologists with option-based incentives, while the current strategy is based on FDA protocols following integration with a hematology biotech.

ELYM: Eliem Therapeutics Net Profit 07/04/2022 - 10/03/2024

Analytical breakdowns and data insights for company eliemtx.com (ELYM)

- stock value and consensus price forecast:
Market Price Eliem Therapeutics Inc.|ELYM - Analyst Consensus Forecast
- business market valuation indicators:
Market Value Eliem Therapeutics Inc.|ELYM - Total Company Value
- balance sheet equity data:
Net Assets per Single Share Eliem Therapeutics|ELYM - Book Capitalization|Market Capitalization to Book Value eliemtx.com|ELYM - Company Total Assets
- debt and liquidity details:
Debt to Capital Eliem Therapeutics|ELYM - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Eliem Therapeutics Inc.|ELYM - Company Total Debt|Debt to Net Assets Ratio Eliem Therapeutics Inc.|ELYM - Company Long-Term Liabilities|Amount of Current Liabilities Eliem Therapeutics|Intermediate Coverage Ratio eliemtx.com
- earnings and valuation multiples information:
ELYM - Net Profit
Summary company analysis:Eliem (ELYM)
Signature product of Eliem Therapeutics, Inc.

For an investor assessing the issuer's financial stability, this indicator reflects the market consensus on current business profitability, calculated daily based on trader expectations. By analyzing the profit dynamics of Eliem Therapeutics (ELYM), one can track the impact of R&D expenditures on the development of epilepsy drugs, where any deviations in the curve signal a reassessment of scientific potential or an increase in operating expenses.

Key competitors

Company Net Income Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Net Profit|Company Net Income regencellbioscience.com RGC|Company Net Income Axsome Therapeutics, Inc. (AXSM)|Company Net Income ACAD (ACADIA Pharma)|Net Profit XENE (Xenon Pharmaceuticals Inc)|Net Financial Result Viking Therapeutics Corp (VKTX)|Supernus Pharmaceuticals - Net Profit|Company Net Income catalystpharma.com|Denali Therapeutics Inc. (DNLI) - Company Net Income|Net Income Harmony Biosciences Inc|Net Income BHVN|AMLX: Final Profit|Net Income TRVI (Trevi Therapeutics)|Profit After Payment of Taxes PRAX|Net Profit AVXL (Anavex Life Sciences Corp.)|Final Profit CBLL|Prothena Biosciences - Net Profit|Company Net Income Alector, Inc.|Annexon, Inc. (ANNX) - Company Net Income|Omeros - Final Profit|NGNE (Neurogene) - Net Profit|Net Profit AC Immune S.A.|Company Net Income Voyager Pharma (VYGR)|NMRA: Profit After Tax|Net Profit SCLX (Scilex Holding Company)|tevogen.com (TVGN) - Company Net Income|ACOG: Net Income|CGTX - Net Profit|IKT (Inhibikase) - Net Income|SAVA: Profit After Payment of Taxes|ASRT (Assertio Holdings) - Net Profit|Coya (COYA) - Net Financial Result|Net Profit VTGN|Net Income ovidrx.com OVID|Company Net Income Acumen Pharma ABOS|Net Financial Result CervoMed Corporation (CRVO)|Alterity Therapeutics Ltd - Net Profit|Company Net Income Clene Inc.|pepgen.com (PEPG) - Company Net Income|JUNS (jupiterneurosciences.com) - Company Net Income|Net Income RLMD|Company Net Income Annovis Bio Corporation ANVS|Company Net Income Grace Therapeutics, Inc. (GRCE)|Net Income fireflyneuro.com AIFF|Company Net Income Klotho Neurosciences KLTO|NRSN: Company Profit|Reviva Pharmaceuticals Holdings - Net Profit|Company Net Income MetaVia Inc|NRXS (NeurAxis, Inc.) - Net Income|Helius Medical Technologies (HSDT) - Net Profit|Company Net Income Passage Bio Inc.|NEUP: Final Profit|Company Net Income Minerva Neurosciences Corp (NERV)|ATHA - Company Net Income|Net Profit ADXN (Addex Therapeutics)|Alzamend Neuro Inc. (ALZN) - Company Net Income|CYCN - Company Net Income|PTIX: Company Net Income|KTTA: Net Profit|CRGT - Net Financial Result|ATXI (Avenue Therapeutics) - Net Profit|Company Net Income brainstorm-cell.com BCLI|Company Net Income Cara Therapeutics (CARA)|Net Income Chromocell Therapeutics Corp CHRO|Intra-Cellular Therapies, Inc. - Net Income|Final Profit LBPH|MRNS: Net Income|nkgenbiotech.com - Profit After Payment of Taxes|NRBO: Net Profit|Sage Therapeutics Inc. - Final Profit|SNPX (Neurotrope) - Net Profit|Company Net Income Trevena Inc TRVN|Company Net Income Vigil Neuroscience (VIGL)|WENA (Anew Medical Inc.) - Final Profit|Net Profit CERE (Cerevel Therapeutics, Inc.)